Recombinant fusion proteins targeting CD47 and CD24, preparation and use thereof | Patent Number 11891449

US 11891449 B2
Application Number17543033
Publication NumberUS 20230114491 A1
Pendency2 years, 2 months, 2 days
Filled DateDec 6, 2021
Priority DateDec 6, 2021
Publication DateApr 13, 2023
Expiration DateDec 5, 2041
Inventor/ApplicantsDianze Chen
Song LI
Wenzhi Tian
Dianze CHEN
Song Li
Wenzhi TIAN
ExaminesEDGINGTONGIORDAN, FRANCESCA
Art Unit1643
Technology Center1600
Assignments
Immuneonco Biopharmaceuticals Shanghai Co. Ltd.
Current
Immuneonco Biopharmaceuticals Shanghai Co. Ltd.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.